SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥146.80+CN¥3.91 (+2.74%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.62% below the high.
Loading market information…
HKSE · 2219.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:02 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Chaoju Eye Care Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Chaoju Eye Care Holdings Limited’s forward annual dividend is HK$0.24 per share, paid annual. The forward yield is 10.31% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Chaoju Eye Care Holdings Limited’s next earnings report is currently expected on Mar 30, 2027, with estimated earnings per share of HK$0.18. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Chaoju Eye Care Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases. In addition, it offers Amblyopia recovery services; and sells eyewear, equipment, and optical products. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| HK$749.10M-57.12% vs estimate |
| Q2 2023 | Aug 29, 2023 | HK$0.23 | HK$748.56M-57.25% vs estimate |
|---|
| Q4 2022 | Mar 28, 2023 | HK$0.14 | HK$232.06M-82.65% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥146.80+CN¥3.91 (+2.74%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.62% below the high.
CN¥49.14+CN¥0.52 (+1.07%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.03% below the high.
HK$51.80+HK$1.15 (+2.27%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.64% below the high.
CN¥181.56+CN¥2.56 (+1.43%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 19.38% below the high.
HK$33.16+HK$0.08 (+0.24%)
Hansoh Pharmaceutical Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 24.83% below the high.
HK$45.52+HK$0.46 (+1.02%)
WuXi Biologics (Cayman) Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.07% below the high.
HK$0.87-HK$0.01 (-1.14%)
C-MER Medical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 53.99% below the high.
HK$2.20HK$0.00 (0.0%)
EuroEyes International Eye Clinic Limited’s quoted price sits in the lower half of its reported 52-week range, 34.33% below the high.
